Candida Albicans

An opportunistic fungal pathogen whose relationship with metals is multifaceted: C. albicans can biosorb heavy metals from its environment, heavy metal exposure promotes its virulence in immunocompromised hosts, and metal nanoparticles are being developed as antifungal weapons against it. This page also covers Cryptococcus neoformans, a related fungal pathogen that uses Ni-dependent urease for brain invasion.

Candida albicans

Metal Biosorption Capacity

C. albicans demonstrates remarkable heavy metal tolerance and uptake [1]:

  • Can grow in concentrations of: 2000 ppm zinc, lead, and copper; 2000 ppm Cr(VI); 1500 ppm As(III); 500 ppm silver; 300 ppm cobalt; 200 ppm mercury and cadmium.
  • Biosorption removal efficiency (modified biomass): Cr(VI) 76%, lead 57%, silver 51%, cadmium 46%, As(III) 40%, cobalt 37%, mercury 36%, copper 31%, zinc 22%.
  • This biosorption capacity means C. albicans in the human GI tract or mucosal surfaces may act as a metal sink, altering local metal bioavailability for both the host and competing microbiota.

Metal Susceptibility in Immunocompromised Hosts

In HIV-positive patients, Candida strains show differential metal susceptibility [2]:

  • 100% resistant to zinc ions (100 mM) — zinc does not inhibit Candida growth.
  • 100% susceptible to cadmium (1 mM), mercury (10 mM), and silver (10 mM).
  • Silver and mercury ions inhibit plasma membrane H+-ATPase by direct binding interactions.
  • Cadmium, mercury, cobalt, and nickel also inhibit plasma membrane ATPase of eukaryotic cells.
  • Implication: in immunocompromised patients, environmental zinc exposure may favor Candida overgrowth while silver/mercury have antifungal potential.

Metal-Dependent Virulence Factors

  • Fe acquisition: C. albicans has dedicated iron uptake systems including reductive iron assimilation (Fre/Ftr/Fet), siderophore uptake (Sit1), and hemoglobin/heme receptors. Iron limitation triggers the yeast-to-hyphae morphological switch — a key virulence transition [3] [4].
  • Cu-SOD: copper-zinc superoxide dismutase for oxidative stress defense within macrophage phagosomes.
  • Zn homeostasis: Zrt1/Zrt2 zinc transporters; zinc is required for alcohol dehydrogenase and numerous metalloenzymes.
  • Magnesium homeostasis: intracellular magnesium is a key immune evasion signal that modulates C. albicans-phagocyte interactions [5].

Beta-Glucan Masking and Immune Evasion

  • C. albicans actively masks cell-wall beta-1,3-glucan from host pattern recognition receptors (Dectin-1), blunting phagocytosis and cytokine responses. Masking is coordinated through a drug-sensitive signaling network that includes PKC, Mkc1, Hog1, and cAMP-PKA [6].
  • The masking program is regulated by Ace2, Mnt1/Mnt2, and multiple MAPK cascades; pharmacologic disruption unmasks beta-glucan and restores host immune recognition [7].
  • Lactate-induced masking: environmental lactate — produced abundantly by gut Lactobacillus and by colonic epithelium — triggers beta-glucan masking, allowing C. albicans to persist as an invisible commensal in the mucosal niche [7].

Interkingdom Synergy with Bacteria

  • Candida-Staphylococcus reciprocal virulence masking: C. albicans and Staphylococcus aureus form mixed biofilms in which each partner masks the other's recognition by host immunity, increasing invasive disease severity in co-infection models [8].
  • C. albicans forms functional biofilms with resident gut and oral bacteria that modulate virulence and persistence [9].

Metal Nanoparticles as Antifungal Strategy

A growing therapeutic approach [10]:

  • Silver nanoparticles (AgNPs): most studied; synergistic with fluconazole against resistant strains; restore susceptibility phenotype by reducing efflux pump activity.
  • Gold nanoparticles (AuNPs): chitosan-functionalized forms inhibit biofilm formation.
  • Iron oxide nanoparticles (IONPs): ferumoxytol (FDA-approved for anemia) disrupts oral Candida biofilms; AMB-IONPs show 16-25x improved efficacy vs. amphotericin B alone.
  • Nickel-containing bimetallic nanoparticles: Ag-NiNPs showed potent activity at 0.19-1.56 ug/mL; Ni-Cu-Zn-IONPs caused complete yeast cell lysis via ROS production and membrane disruption.

Cryptococcus neoformans -- Ni-Urease for Brain Invasion

C. neoformans uses a Ni-dependent urease that is essential for CNS invasion [11]:

  • Urease activity promotes crossing of the blood-brain barrier.
  • Urease-negative mutants show dramatically reduced brain colonization in animal models.
  • Ammonia production from urease may damage endothelial tight junctions (paralleling helicobacter pylori urease disruption of gastric tight junctions).
  • C. neoformans causes cryptococcal meningitis, a leading killer of HIV/AIDS patients, making its Ni-urease a critical virulence factor in the global HIV burden.

Nutritional Immunity and Fungal Pathogens

  • Host calprotectin sequesters zinc and manganese at infection sites, inhibiting Candida growth and hyphal morphogenesis.
  • Lactoferrin and transferrin restrict iron, slowing fungal proliferation.
  • C. albicans evades iron restriction through reductive iron uptake and hemoglobin binding.
  • Copper intoxication: macrophages pump copper into phagosomes to kill engulfed Candida; the fungus counters with Cu-SOD and copper exporters.

Disease Associations

Candida albicans

  • Oral thrush (especially HIV/AIDS)
  • Vulvovaginal candidiasis
  • Invasive candidiasis / candidemia (ICU patients, post-surgical)
  • Chronic mucocutaneous candidiasis
  • Esophageal candidiasis
  • Gastric colonization with PPI use: proton pump inhibitor therapy raises gastric pH and drives fungal dysbiosis with Candida overgrowth, contributing to GERD-associated fungal disease [12].
  • Autism spectrum disorder: elevated anti-Candida antibodies have been reported in children with ASD [13].
  • Schizophrenia / bipolar disorder: C. albicans seropositivity is associated with psychiatric diagnosis in a sex-specific manner [14].
  • Lung cancer ecology: Candida expansion occurs in dysbiotic lung and gut microbiomes of cancer patients [15].

Cryptococcus neoformans

  • Cryptococcal meningitis (HIV/AIDS, transplant recipients)
  • Pulmonary cryptococcosis

Connection to Environmental Metal Exposure

  • C. albicans biosorption capacity means it may accumulate dietary heavy metals in the gut, potentially sequestering metals from absorption or concentrating them in biofilms.
  • In immunocompromised patients, environmental zinc exposure may support C. albicans (which is zinc-resistant) while suppressing zinc-sensitive competitors, promoting overgrowth.
  • Heavy metal contamination in water/food may indirectly promote fungal pathogenesis by disrupting competing bacterial microbiota.
  • For C. neoformans, environmental nickel availability (soil, bird droppings — its natural habitat) supports urease metalation that enables subsequent brain invasion.

Connections

  • metal dependent virulence — C. neoformans Ni-urease for brain invasion; C. albicans Fe-dependent morphological switch
  • nickel — cofactor for C. neoformans urease (brain invasion); component of antifungal bimetallic nanoparticles
  • iron — essential for C. albicans yeast-to-hyphae transition; target of host nutritional immunity
  • zincC. albicans is highly zinc-resistant; host calprotectin sequesters Zn as defense
  • copper — host macrophages use Cu intoxication against engulfed Candida
  • nutritional immunity — host deploys calprotectin, lactoferrin, Cu intoxication against fungal pathogens
  • helicobacter pyloriC. neoformans urease parallels H. pylori urease in disrupting tight junctions
  • proteus mirabilis — both use Ni-urease for pathogenesis in different niches

References (19)

  1. Ismael Acosta Rodriguez, Juan Fernando Cardenas-Gonzalez, Victor Manuel Martinez Juarez et al. (2018). Biosorption of Heavy Metals by Candida albicans. Advances in Bioremediation and Phytoremediation (IntechOpen)
  2. Monal M. Kukde, Silpi Basak, Deepak P. Selkar (2019). Effect of Heavy Metal Ions on Candida Isolated from HIV Positive Patients. Journal of Clinical and Diagnostic Research
  3. Jeanne Corrales, Lucia Ramos-Alonso, Javier Gonzalez-Sabin et al. (2024). Corrales 2024 — Characterization of a Selective, Iron-Chelating Antifungal Compound That Disrupts Fungal Metabolism and Synergizes with Fluconazole. Microbiology Spectrum. doi:10.1128/spectrum.03009-23
  4. Alves R, et al. (2020). Alves et al. 2020 — Adapting to Survive: How Candida Overcomes Host-Imposed Constraints. PLoS Pathogens. doi:10.1371/journal.ppat.1008478
  5. Hans S, et al. (2022). Hans et al. 2022 — Magnesium Deprivation Causes Candida Beta-Glucan Unmasking and Immune Evasion Changes. PLoS ONE. doi:10.1371/journal.pone.0270676
  6. Wheeler RT, Fink GR (2006). Wheeler & Fink 2006 — A Drug-Sensitive Genetic Network Masks Fungi from the Immune System. PLoS Pathogens. doi:10.1371/journal.ppat.0020035
  7. Chen T, Wagner AS, Reynolds TB (2022). Chen, Wagner & Reynolds 2022 — Beta-Glucan Masking Signaling Pathways in Candida. Frontiers in Fungal Biology. doi:10.3389/ffunb.2022.842501
  8. Pasman ME, et al. (2025). Pasman et al. 2025 — Candida-Staphylococcus Reciprocal Virulence and Masking in Co-culture. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2025.1629373
  9. Li XV, et al. (2022). Li et al. 2022 — Candida albicans and Resident Microbiota Interactions. Frontiers in Microbiology. doi:10.3389/fmicb.2022.930495
  10. Paulo Henrique Fonseca do Carmo, Maira Terra Garcia, Livia Mara Alves Figueiredo-Godoi et al. (2023). Metal Nanoparticles to Combat Candida albicans Infections: An Update. Microorganisms. doi:10.3390/microorganisms11010138
  11. Robert J. Maier, Stéphane L. Benoit (2019). Role of Nickel in Microbial Pathogenesis. Inorganics. doi:10.3390/inorganics7070080
  12. Yichao Shi, Jianfeng Li, Shuntian Cai et al. (2023). Shi 2023 — PPI-Induced Fungal Dysbiosis in Patients with Gastroesophageal Reflux Disease. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2023.1205348
  13. Heather K. Hughes, Paul Ashwood (2018). Hughes 2018 — Anti-Candida albicans IgG Antibodies in Children With Autism Spectrum Disorders. Frontiers in Psychiatry. doi:10.3389/fpsyt.2018.00627
  14. Emily G. Severance, Kristin L. Gressitt, Catherine R. Stallings et al. (2016). Severance 2016 — Candida albicans Exposures, Sex Specificity and Cognitive Deficits in Schizophrenia and Bipolar Disorder. npj Schizophrenia. doi:10.1038/npjschz.2016.18
  15. Seelbinder B, et al. (2023). Seelbinder et al. 2023 — Candida Expansion in the Gut Is Determined by Bacterial Ecology. Nature Communications. doi:10.1038/s41467-023-38058-8
  16. Dominika Bartnicka, Miriam Gonzalez-Gonzalez, Joanna Sykut et al. (2020). Bartnicka et al. 2020 — Candida albicans Shields the Periodontal Killer Porphyromonas gingivalis from Recognition by the Host Immune System and Supports the Bacterial Infection of Gingival Tissue. International Journal of Molecular Sciences. doi:10.3390/ijms21061984
  17. Yiyuan Pan, Zhaoling Shi, Yadong Wang et al. (2024). Pan et al. 2024 — Baicalin Promotes β-1,3-Glucan Exposure in Candida albicans and Enhances Macrophage Response. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2024.1487173
  18. XiaoHui Sem, Giang T. T. Le, Alrina S. M. Tan et al. (2016). Sem et al. 2016 — β-Glucan Exposure on the Fungal Cell Wall Tightly Correlates with Competitive Fitness of Candida Species in the Mouse Gastrointestinal Tract. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2016.00186
  19. Andrew S. Wagner, Stephen W. Lumsdaine, Mikayla M. Mangrum et al. (2022). Wagner et al. 2022 — Cek1 Regulates ß(1,3)-Glucan Exposure Through Calcineurin Effectors in Candida albicans. PLOS Genetics. doi:10.1371/journal.pgen.1010405